Cargando…
Barrett’s Esophagus and Cancer Risk: How Research Advances Can Impact Clinical Practice
Barrett’s esophagus (BE) is the only known precursor to esophageal adenocarcinoma (EAC), whose incidence has increased sharply in the last 4 decades. The annual conversion rate of BE to cancer is significant, but small. The identification of patients at a higher risk of cancer therefore poses a clin...
Autores principales: | di Pietro, Massimiliano, Alzoubaidi, Durayd, Fitzgerald, Rebecca C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Gut and Liver
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113043/ https://www.ncbi.nlm.nih.gov/pubmed/25071900 http://dx.doi.org/10.5009/gnl.2014.8.4.356 |
Ejemplares similares
-
Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett’s esophagus-related neoplasia
por: Alzoubaidi, Durayd, et al.
Publicado: (2019) -
Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus
por: Waterhouse, Dale J., et al.
Publicado: (2021) -
The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study
por: Phillips, Richard, et al.
Publicado: (2021) -
TissueCypher Barrett’s esophagus assay impacts clinical decisions in the management of patients with Barrett’s esophagus
por: Diehl, David L., et al.
Publicado: (2021) -
Histopathology in Barrett Esophagus and Barrett Esophagus-Related Dysplasia
por: Grin, Andrea, et al.
Publicado: (2014)